Association Between Acid-Suppressive Agents' Use and Risk of Hepatocellular Carcinoma.

Lin, Hsiu C; Hsu, Huan Y; Lin, Hsiu L; Uang, Yow S; Ho, Yi; Wang, Li H

Lin, Hsiu C; Hsu, Huan Y; Lin, Hsiu L; Uang, Yow S; Ho, Yi; Wang, Li H.

Afiliação

Lin HC; Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, Taipei.
Hsu HY; Department of Clinical Pathology, Taipei Medical University Hospital, Taipei.
Lin HL; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei.
Uang YS; Department of Neurology, General Cathay Hospital, Sijhih Branch, New Taipei City.
Ho Y; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei.
Wang LH; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei.

Dose Response ; 18(2): 1559325820907530, 2020.

Article em En | MEDLINE | ID: mdl-35185412

Palavras-chave

acid-suppressive agents; dose-dependent; hepatocellular carcinoma; histamine 2 receptor antagonists; proton pump inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Dose Response Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google